Safety and Efficacy of Hypofractionated Radiotherapy and Concurrent Chemotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer

被引：0
|
作者：
Zhang, Q. [1 ]
Fu, X. L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2274
引用
收藏
页码：E124 / E124
页数：1
相关论文
共 50 条
  • [41] Optimal chemotherapy regimen for concurrent chemo-radiotherapy of locally advanced unresectable stage III non-small cell lung cancer (NCSLC)
    Jokhadze, N.
    Kiladze, I.
    Katselashvili, L.
    Kacharava, M.
    Jankarashvili, N.
    Zumbadze, I.
    Kalandarishvili, N.
    Melkadze, T.
    Gogua, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S66 - S67
  • [42] Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
    John Conibear
    British Journal of Cancer, 2020, 123 : 10 - 17
  • [43] Use of Hypofractionated Radiation Therapy With Concurrent Chemotherapy in Inoperable Stage II/III Non-small Cell Lung Cancer
    Kim, E.
    Westover, K. D.
    Daly, M. E.
    Murphy, J. D.
    Mitin, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E468 - E468
  • [44] Outcomes of Hypofractionated Radiation Therapy (HFRT) with Concurrent Chemotherapy in Patients with Stage III Non Small Cell Lung Cancer (NSCLC)
    Shepherd, A.
    Gelblum, D.
    Wu, A.
    Rimner, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S661 - S662
  • [45] Hypofractionated vs Conventionally Fractionated Radiation Therapy with Concurrent Chemotherapy for Stage III Non-small Cell Lung Cancer
    Sasse, Alexander
    Jairam, Vikram
    Saeed, Nadia
    Park, Henry
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S109 - S110
  • [46] Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
    Conibear, John
    BRITISH JOURNAL OF CANCER, 2020, 123 (SUPPL 1) : 10 - 17
  • [47] Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
    Kerner, Gerald S. M. A.
    van Dullemen, Leon F. A.
    Wiegman, Erwin M.
    Widder, Joachim
    Blokzijl, Edwin
    Driever, Ellen M.
    van Putten, John W. G.
    Liesker, Jeroen J. W.
    Renkema, Tineke E. J.
    Pieterman, Remge M.
    Mertens, Marc J. F.
    Hiltermann, Thijo J. N.
    Groen, Harry J. M.
    RADIATION ONCOLOGY, 2014, 9
  • [48] Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
    Gerald SMA Kerner
    Leon FA van Dullemen
    Erwin M Wiegman
    Joachim Widder
    Edwin Blokzijl
    Ellen M Driever
    John WG van Putten
    Jeroen JW Liesker
    Tineke EJ Renkema
    Remge M Pieterman
    Marc JF Mertens
    Thijo JN Hiltermann
    Harry JM Groen
    Radiation Oncology, 9
  • [49] Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
    Seung, S. J.
    Hurry, M.
    Walton, R. N.
    Evans, W. K.
    CURRENT ONCOLOGY, 2020, 27 (04) : E354 - E360
  • [50] Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer
    Masaru Nakamura
    Tomonobu Koizumi
    Munehara Hayasaka
    Masanori Yasuo
    Kenji Tsushima
    Keishi Kubo
    Kotaro Gomi
    Naoto Shikama
    Cancer Chemotherapy and Pharmacology, 2009, 63
12345